<DOC>
	<DOCNO>NCT01932203</DOCNO>
	<brief_summary>There may difference efficacy cilostazol aspirin progression white matter change cerebal small vessel disease .</brief_summary>
	<brief_title>Efficacy Study Cilostazol Aspirin Cerebral Small Vessel Disease</brief_title>
	<detailed_description>The primary objective study compare efficacy aspirin cilostazol volume white matter change cerebral small vessel disease . The secondary objective compare impact aspirin cilostazol DTI parameter , lacune , microbleeds , brain atrophy , cognition , depression , neurologic sign , gait , urination , activity daily live . We also investigate risk factor associate progression cerebral small vessel disease .</detailed_description>
	<mesh_term>Cerebral Small Vessel Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>50 85 year age He/She walk hospital ( walker cane permissible ) . Cerebral small vessel disease oberved brain MRI . 1 ) presence one lacunar infarction 2 ) moderate severe confluenct leukoaraiosis ( define grade 2 3 modify Fazekas scale ) : periventricular WMCs cap rim lager 5mm deep subcortical WMCs &gt; 10 mm maximum diameter write informed consent Any patient contraindication antiplatelets Any patient cardioembolic source Carotid bruit large cerebral artery stenosis &gt; 50 % Cortical infarction subcortical infarction lager 1.5 cm bleeding tendency chronic liver disease ( AST ALT &gt; 100 IL/L ) chronic renal disease ( Creatinine &gt; 3.0mg/dL ) active gastrointestinal ulcer patient severe unstable medical disease may prevent complete study requirement ( i.e. , unstable severe asthma ) Anemia ( Hb &lt; 10g/dL ) thrombocytopenia Cardiac pacemaker contraindication MRI Pregnancy breastfeed drug alcohol addiction Any white matte disease ( i.e. , Multiple sclerosis , sarcoidosis , brain irradiation , etc ) brain tumor Parkinson 's disease , Alzheimer 's disease neurodegenerative disease hear visual impairment disturb efficient evaluation patient recent cerebral infarction 3 month</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cerebral small vessel disease</keyword>
	<keyword>Leukoaraiosis</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Diffusion Tensor Imaging</keyword>
</DOC>